Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | TSPO | P30536 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14362633 | 0.99 | GPR3 (0.46) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL2613157 | 0.94 | TSPO (0.43) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL18564772 | 0.93 | GPR3 (0.48) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL12596052 | 0.92 | KDM4E (0.43) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL14362490 | 0.90 | BCHE (0.43) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL12559383 | 0.90 | GPR3 (0.55) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL12249804 | 0.90 | GPR3 (0.55) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL13291217 | 0.89 | KMT2A (0.40) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL24797249 | 0.88 | KDM4E (0.41) | KDM4EGPR3HPGDALDH1A1MAPT | |
| SCHEMBL13291114 | 0.88 | HSD17B10 (0.39) | KDM4EGPR3HPGDALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070075632-A1 | Anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-20070075632-A1 | Anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| WO-2007029530-A1 | ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070075632-A1 | Anthracene derivative | CRY2, XPOT, CRY1 | KDM4E 3133/4885GPR3 4089/4885HPGD 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.